Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 4/20 | 0.44 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.44 |
| ▸ | ESR1 | P03372 | 2/20 | 0.42 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | HTR1A | P08908 | 1/20 | 0.37 |
| ▸ | CRHR1 | P34998 | 4/20 | 0.37 |
| ▸ | ELANE | P08246 | 1/20 | 0.36 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18590933 | 0.89 | ELANE (0.40) | GABRA1GABRB2ESR1NR1I2TP53 | |
| SCHEMBL18289166 | 0.84 | ELANE (0.35) | GABRA1GABRB2ESR1NR1I2TP53 | |
| SCHEMBL18289179 | 0.84 | ELANE (0.35) | GABRA1GABRB2ESR1NR1I2TP53 | |
| SCHEMBL11140943 | 0.83 | TDP1 (0.46) | GABRA1GABRB2ESR1NR1I2TP53 | |
| SCHEMBL18289117 | 0.83 | ELANE (0.35) | GABRA1GABRB2ESR1NR1I2TP53 | |
| SCHEMBL10399130 | 0.81 | GABRA1 (0.48) | GABRA1GABRB2NR1I2TP53MEN1 | |
| SCHEMBL30338128 | 0.81 | NR1I2 (0.60) | GABRA1GABRB2ESR1NR1I2TP53 | |
| SCHEMBL20202898 | 0.80 | CRHR1 (0.34) | GABRA1GABRB2ESR1NR1I2MEN1 | |
| SCHEMBL18289141 | 0.80 | GABRA1 (0.43) | GABRA1GABRB2ESR1NR1I2TP53 | |
| SCHEMBL18289153 | 0.79 | ALDH1A1 (0.37) | ESR1TP53MEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230019844-A1 | LIGHT EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230019844-A1 | LIGHT EMITTING DEVICE | USE1, SLC18A1, TMEM109 | GABRA1 2945/4885GABRB2 3164/4885ESR1 15/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.